Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

‘Dirty mice’ better mirror humans, says researcher

25-Apr-2016 - Mice are used to model various human diseases – yet the animals don’t replicate some significant features of the adult human immune system.

Stem cells form tiny beating heart for drug testing

22-Apr-2016 - While there are currently several techniques for producing tissue from heart cells, a new method reduces the amount of cells needed, making it easier and cheaper to replicate.

Aptuit bolsters its preclinical services with Exquiron acquisition

21-Apr-2016 - Aptuit has acquired Swiss CRO Exquiron Biotech, enhancing its drug identification and validation services.

Johnson Matthey and Domainex team on API discovery and development

19-Apr-2016 - Johnson Matthey has teamed up with Domainex to offer integrated API discovery, preclinical development and manufacturing services. 

Building a better biomedical knowledgebase

18-Apr-2016 - Researchers as The Scripps Research Institute (TSRI) are working to create a public database where researchers can easily access biomedical knowledge.

Pierre Fabre signs on second partner to innovation program

14-Apr-2016 - Pierre Fabre laboratories has established a partnership with a biotech company as part of its Open Innovation program, "Nature Open Library."

Zika vaccine-blocker candidate being tested in animals

14-Apr-2016 - Replikins’ genomic understanding of the Zika and Flaviviruses has led to the development of a trivalent vaccine for Zika, Dengue, and Japanese Encephalitis. 

US 'foots the bill' for global biopharma innovation, says ITIF

12-Apr-2016 - The US ranks first in terms of how its domestic policies contribute to global biopharmaceutical innovation, according to a recent analysis.

Vaccines and biologics driving Charles River investments

12-Apr-2016 - Demand for biological products has driven recent investments in vaccine manufacturing and cell banking, says Charles River Laboratories.

New program to expedite clinical trials through data sharing

11-Apr-2016 - Finding the right patients quickly is an ongoing problem in launching clinical trials, so several companies have formed an alliance to advance precision medicine development. 

Microbial or mammalian? BioSilta backs the former licensing E. Coli platform

08-Apr-2016 - Microbial expression systems are cheaper and more efficient than mammalian cell cultures says BioSilta which has acquired the rights to an E. coli based platform.

Mouse model to aid Zika vaccine testing

06-Apr-2016 - Researchers have established a new mouse model for testing vaccines and therapeutics to fight the Zika virus.

CrownBio develops mouse strains with human PD-1 for mAb testing

05-Apr-2016 - Crown Bioscience has developed humanized mouse cancer models which it claims provide biologic drug developers with an improved means of assessing efficacy.

Pharma Consortium to investigate new drug development technique

04-Apr-2016 - The new consortium will evaluate cryo-electron microscopy’s potential for drug development.

SGS and DiscoverX to supply bioassays for biosimilar development

04-Apr-2016 - SGS has teamed with DiscoverX to offer bioassays for assessing the potency of prospective biosimilars of Roche’s Avastin and BMS’s Erbitux.

Eurofins agrees to buy US analytical services firm Advantar Laboratories

01-Apr-2016 - Eurofins Scientific has agreed to buy analytical services firm Advantar Laboratories in its latest deal in the pharmaceutical space.

New WCG board to advise on gene therapy research

30-Mar-2016 - WIRB-Copernicus Group (WCG) has assembled a team of experts to advise the company as it advances its gene therapy research. 

AAALAC accreditation for Envigo lab in the Netherlands

29-Mar-2016 - Lab animal treatment watchdog AAALAC has accredited an Envigo models facility and distribution centre in the Netherlands.

Quanterix raises $46m with goal of adding 60 new assays

23-Mar-2016 - The funding will be used to accelerate the company’s global expansion of its proprietary digital immunoassay platform into new markets.

Propanc receives $1.2m to fast track preclinical studies

22-Mar-2016 - Propanc Health Group Corporation has received $1.2m from an institutional investor in order to fast track preclinical activities for its lead product, PRP.

Any old ion? Metrion gets grant to develop better stem cell-based cardiac risk assays

21-Mar-2016 - Metrion Biosciences has been awarded a grant to develop CiPA-compliant stem cells and screening technologies by Eurostars, a European Union (EU) programme.

Samsara Sciences signs up QPS as liver cell distributor

15-Mar-2016 - QPS Holdings will distribute liver cells made by Samsara Sciences under a deal agreed last week.

Sanofi aiming to 'cut years off' vaccine development timelines for Zika says R&D head

15-Mar-2016 - Sanofi Pasteur, the vaccines division of Sanofi, has launched a vaccine research and development project targeting the prevention of Zika virus infection and disease.

I/O therapies boosting R&D funding & alliances, says Tufts

09-Mar-2016 - With more than 130 biotech and 20 pharmaceutical companies currently developing immuno-oncology (I/O) therapies, the global oncology market could reach $40bn by 2020, says Tufts.

Crown Bioscience acquires PreClinOmics, adds CVMD models to portfolio

09-Mar-2016 - Crown Bioscience has announced the acquisition of PreClinOmics, an in vivo preclinical company specializing in early research in cardiovascular and metabolic diseases (CVMD).

Key Industry Events


Access all events listing

Our events, Shows & Conferences...